Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference

François Briand en LinkedIn: #ksns #nash #obesity #drugdevelopment

Biomedicines, Free Full-Text

François Briand en LinkedIn: #nash #fibrosis #obesity

Differential Pathophysiological Mechanisms in Heart Failure With a

Frontiers Microvascular Dysfunction in Heart Failure With

Elafibranor improves diet-induced nonalcoholic steatohepatitis

François Briand en LinkedIn: #aasld #tlm22 #nash #liverdisease

François Briand en LinkedIn: #nash #fibrosis #obesity

François Briand on LinkedIn: Preclinical CRO for metabolic

Development and Challenges of Pre-Heart Failure with Preserved